Articles by Sanjukta Mondal
Phys.org / New discoveries reveal Tell Abraq's role in ancient Persian Gulf trade
If there were a place that could be called the archaeological almanac of Saudi Arabian culture, it would be Tell Abraq, located on the west coast of the United Arab Emirates. This area contains traces of every cultural phase ...
Phys.org / Secret behind Temple of Venus's resilient construction uncovered
The material used to build the Temple of Venus in Naples has remarkably endured even as Earth's surface around it sank from volcanic activity, and researchers were curious to know how.
Tech Xplore / Soft robots harvest ambient heat for self-sustained motion
A warm hand is enough to drive motion in tiny Salmonella-inspired robots that harness molecular-level dynamic bonding.
Phys.org / Ancient Maya game board with unique mosaic design discovered in Guatemala
Centuries before Monopoly, there was Patolli, a high-stakes Mesoamerican game of strategy and luck where players wagered crops and wealth as they raced their opponents around a cross-shaped board.
Medical Xpress / Nighttime phone use linked to higher levels of suicidal thoughts in high-risk adults
Patterns of smartphone use and their impact on mental health are being extensively studied due to the growing dependence of the device in people's lives.
Phys.org / The Suez Rift—once deemed inactive—is still drifting, study reveals
The tectonic plates under Africa and Asia are slowly drifting apart, as the Gulf of Suez that separates these two land masses continues to widen at a rate of about 0.26–0.55 millimeters per year.
Medical Xpress / CD21 downregulation found to trigger harmful B cells in lupus
Our body's immune system is quick to spring into action when it spots a foreign object that shouldn't be there. Sometimes the same defense mechanism can get confused and end up attacking the very cells it's meant to protect, ...
Phys.org / New synthesis strategy for (–)-gukulenin A reveals the chemistry behind its anticancer effects
A team of researchers from Yale University, U.S., successfully achieved the first stereoselective synthesis of the complex natural product (–)-gukulenin A (7), which exhibits notable cytotoxicity against ovarian cancer.
Phys.org / Speaking more than one language may help the brain stay younger
Speaking more than one language can slow down the brain's aging and lower risks linked to accelerated aging.
Phys.org / New enzyme network with competing peptides can make decisions based on external environment
The ability to respond to changing surroundings was once considered exclusive to complex living organisms. Then came computers, specially designed for stimulus–response tasks, which can take in signals from their environment ...
Phys.org / One-pot method synthesizes blue light-responsive aryne precursors from carboxylic acids
Arynes are highly reactive organic intermediates featuring a triple bond within an aromatic ring. Their strong reactivity enables them to form bonds with a wide range of functional groups, making them valuable tools for the ...
Phys.org / Iron core-shell catalyst boosts hydrogen economy of direct syngas to olefin conversion
Scientists have developed a new iron-based catalyst that improves the typically low hydrogen atom economy (HAE) in the direct synthesis of olefins—small hydrocarbon molecules. It converts the water produced as a by-product ...
Phys.org / Stone Age Pacific fishing practices revealed through chemical fingerprints hidden in collagen
A new collagen fingerprinting tool can help scientists identify species from archaeological bone fragments. Pacific islanders of the late Stone Age, also known as the Neolithic period, were master fishers. Archaeological ...
Phys.org / Improved iron catalysts achieve near-zero CO₂ emissions in liquid fuel synthesis from syngas
Scientists cut down over 99% of the CO2 production during the conversion of crude oil products into fuels.
Medical Xpress / Clinical trial presents promising DNA-encoded therapy for long-lasting protection against COVID-19
A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting pre-made antibodies into patients, this approach encouraged the body to produce its own antibodies to ...
